Senior insider sale
President, R&D at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$2.61M
169.31K shares
What this filing means
PLUMP ANDREW STEWART plans to sell 169.31K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $2.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2025ACC: 0001977689-25-000004
DirectorOfficer· President, R&D
Since Mar 2026
169.31K
Shares to sell
$2.61M
Approx. market value
363.57K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2025
363.57KTotal acquired363.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Restricted Stock Unit Awards - Vested. Compensation | 363.57K | — |
| Total | 363.57K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
169.31K
Market value
$2.61M
7/9/2025
Total
Units
169.31K
Value
$2.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/9/2025 | 169.31K | $2.61M | NYSE | Planned |
| Total | 169.31K | $2.61M | ||